Evolus Stock

Evolus Current Ratio

The Current Ratio of Evolus (EOLS) as of Aug 8, 2026 is 1.38. In the previous year, Current Ratio was 1.98 — a change of -30.00% (lower).

Current Ratio

1.38

YoY

-30.00%

Last updated:

Current Ratio of Evolus is 2026 1.38 . Current Ratio of Evolus was 2025 1.98 . It decreases by -30.00% lower compared to the previous year.
Access this data via the Eulerpool API

Evolus Stock analysis

What does Evolus do? Evolus Inc is an innovative biotechnology company based in Irvine, California, specializing in the development and distribution of aesthetic treatments. The company was founded in 2012 and has quickly become a market leader in the industry. Evolus is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Evolus stock

Current Ratio of Evolus is 1.38 in 2026.

Current Ratio of Evolus changed from 1.98 to 1.38, representing a -30.00% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Current Ratio Evolus since 2006 – with annual values, charts, and detailed analysis.

The Current Ratio measures a company's ability to pay short-term obligations. A ratio above 1 indicates that current assets exceed current liabilities.

Current Ratio = Current Assets / Current Liabilities

A 'good' varies by industry and company stage. On Eulerpool, you can compare Current Ratio's Evolus with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

Leverage — Evolus

All Key Metrics — Evolus